Bleeding Disorders Canada: CHS Dream of a Cure Research Program
Sponsor’s Website
Visit the Bleeding Disorders Canada website for more information on the CHS Dream of a Cure Research Program
Internal Contact
Potential applicants are encouraged to discuss this funding opportunity with their Faculty Research Facilitator.
OVPRII contact: CORIS@carleton.ca
Deadlines
| Deadline | Date |
|---|---|
| Faculty deadline | Consult your Faculty Research Facilitator |
| Internal cuResearch Approval Form | November 20, 2026 |
| Submission of full application | November 27, 2026 |
Overview
The CHS Dream of a Cure Research Program, through funds provided by the Hemophilia Research Million Dollar Club and Canadian Hemophilia Society, supports research focused on improving the health and the quality of life of all people with inherited bleeding disorders and finding a cure. The Canadian Hemophilia Society invites applicants to apply for basic scientific research grants in fields relevant to hemophilia A and B, von Willebrand disease, rare factor deficiencies, platelet function disorders (and platelet pathophysiology) and other congenital and acquired bleeding disorders.
Value and Duration
Individual grants valued at $75,000 per year and per project will be awarded to researchers for a maximum of $150,000 which can be expended over two or three years. If a two-year award is provided, the second year of funding is dependent on evidence of progress as described in the required progress report. Grant funding will begin on April 1 of each year.
Yearly grants will normally be disbursed in two payments in each year.
Eligibility
Applicants must be Canadian citizens or permanent residents and affiliated with a Canadian university or not-for-profit health-related organization.
Submitting Your Application
- Submit an internal Approval Form through our central awards management database cuResearch. Consult the user’s manual for guidance.
- Submit an external application to Bleeding Disorders Canada by following their submission guidelines.